3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
25 26 0 1 0 0 0 0 0999 V2000
3.3629 -0.9451 -0.6276 O 0 0 0 0 0 0 0 0 0 0 0 0
1.5447 -0.2713 0.7083 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.2122 -1.2398 -0.9753 N 0 0 0 0 0 0 0 0 0 0 0 0
0.5328 0.7738 0.6884 C 0 0 1 0 0 0 0 0 0 0 0 0
1.1232 1.7938 -0.2846 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0055 0.9714 -1.2195 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4306 -0.1994 -0.3661 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8487 0.3052 0.2799 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5954 -1.2676 1.7600 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9852 0.9475 0.7502 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0097 -0.7723 -0.5715 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2402 0.4957 0.3572 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2990 -0.5919 -0.4992 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4827 1.2056 1.6961 H 0 0 0 0 0 0 0 0 0 0 0 0
1.7631 2.4925 0.2706 H 0 0 0 0 0 0 0 0 0 0 0 0
0.3797 2.3883 -0.8248 H 0 0 0 0 0 0 0 0 0 0 0 0
2.8735 1.5405 -1.5611 H 0 0 0 0 0 0 0 0 0 0 0 0
1.4424 0.5973 -2.0799 H 0 0 0 0 0 0 0 0 0 0 0 0
2.4305 -1.9529 1.5936 H 0 0 0 0 0 0 0 0 0 0 0 0
0.6601 -1.8329 1.7699 H 0 0 0 0 0 0 0 0 0 0 0 0
1.7288 -0.7596 2.7187 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.9076 1.7995 1.4196 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.1703 -1.3201 -0.9859 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.1436 0.9799 0.7097 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.2537 -0.9828 -0.8356 H 0 0 0 0 0 0 0 0 0 0 0 0
1 7 2 0 0 0 0
2 4 1 0 0 0 0
2 7 1 0 0 0 0
2 9 1 0 0 0 0
3 11 1 0 0 0 0
3 13 2 0 0 0 0
4 5 1 0 0 0 0
4 8 1 0 0 0 0
4 14 1 0 0 0 0
5 6 1 0 0 0 0
5 15 1 0 0 0 0
5 16 1 0 0 0 0
6 7 1 0 0 0 0
6 17 1 0 0 0 0
6 18 1 0 0 0 0
8 10 1 0 0 0 0
8 11 2 0 0 0 0
9 19 1 0 0 0 0
9 20 1 0 0 0 0
9 21 1 0 0 0 0
10 12 2 0 0 0 0
10 22 1 0 0 0 0
11 23 1 0 0 0 0
12 13 1 0 0 0 0
12 24 1 0 0 0 0
13 25 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
1-methyl-5-pyridin-3-ylpyrrolidin-2-one
4.2 InChl
InChI=1S/C10H12N2O/c1-12-9(4-5-10(12)13)8-3-2-6-11-7-8/h2-3,6-7,9H,4-5H2,1H3
4.3 InChlKey
UIKROCXWUNQSPJ-UHFFFAOYSA-N
4.4 Canonical SMILES
CN1C(CCC1=O)C2=CN=CC=C2
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病